Avid Bioservices Inc (CDMO)

[freethemice]

Connecting the dots: Thorpe, Gerber, Schiller --> Peregrine.

Meet Dr. Joan Schiller Oncologist and Lung Cancer Specialist
Andrea L. Simmons Distinguished Chair in Cancer Research
Dr. Schiller is Professor and Chief of the Division of Hematology-Oncology at UT Southwestern Medical Center
and Deputy Director of Simmons Cancer Center. She is founder and president of the National Lung Cancer Partnership.
http://profiles.utsouthwestern.edu/profile/81890/joan-schiller.html

Fellow of the American Society of Clinical Oncology
An award given for dedication and volunteer efforts in the field of medical oncology (2013)
American Thoracic Society's 2011 William J Marting II Distinguished Achievement award (2011)

Lung Cancer Medical Oncology Team
Jonathan Dowell, M.D.
David Gerber, M.D. <- gave the Chicago talk on Sept 7th
Randall Hughes, M.D.

If you do a pubmed search on her you get a list of 176 papers.
She is a major player in the clinical oncology of lung cancer. She is
very connected with all the big clinical oncologists in lung cancer.
One of the Associate Editors for the Journal of Clinical Oncology
http://jco.ascopubs.org/site/misc/edboard.xhtml

Both of these papers were just published online in Journal of Clincal Oncology, Feb 11, 2013
Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old Idea
David E. Gerber and Joan H. Schiller

Non–Small-Cell Lung Cancer: Then and Now
Joan H. Schiller, University of Texas Southwestern Medical Center, Dallas, TX
David R. Gandara, University of California, Davis, Comprehensive Cancer Center, Sacramento, CA
Glenwood D. Goss, The Ottawa Hospital Cancer Centre; University of Ottawa; and NCIC Clinical Trials Group, Ottawa,
Ontario, Canada
Everett E. Vokes, The University of Chicago Medical Center, Chicago, IL

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
Employment or Leadership Position: None Consultant or Advisory
Role: Joan H. Schiller, AdventRx Pharmaceuticals (C), Agennix (C),
ArQule (C), AVEO (C), Clovis Oncology (C), Daiichi Sankyo (C), EMD
Serono (C), Genentech (U), GlaxoSmithKline (C), Merck (C), Novartis
(C), Peregrine (C), Pfizer (C), Threshold Pharmaceuticals (C);